S

Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294

Watchlist Manager
Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294
Watchlist
Price: 52.02 CNY -0.9% Market Closed
Market Cap: 58B CNY

Intrinsic Value

The intrinsic value of one Shenzhen Salubris Pharmaceuticals Co Ltd stock under the Base Case scenario is 26.22 CNY. Compared to the current market price of 52.02 CNY, Shenzhen Salubris Pharmaceuticals Co Ltd is Overvalued by 50%.

Intrinsic Value
26.22 CNY
Overvaluation 50%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation History
Shenzhen Salubris Pharmaceuticals Co Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about Shenzhen Salubris Pharmaceuticals Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Shenzhen Salubris Pharmaceuticals Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Shenzhen Salubris Pharmaceuticals Co Ltd.

Explain Valuation
Compare Shenzhen Salubris Pharmaceuticals Co Ltd to
Custom
Choose any stock to compare

Fundamental Analysis

Profitability Score
Profitability Due Diligence

Loading...
Loading...
Loading...
Loading...
Profitability
Score

Solvency Score
Solvency Due Diligence

Loading...
Loading...
Loading...
Loading...
Solvency
Score
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Shenzhen Salubris Pharmaceuticals Co Ltd?
Bearish
Neutral
Bullish
Efficiency

Free Cash Flow Analysis
Shenzhen Salubris Pharmaceuticals Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Shenzhen Salubris Pharmaceuticals Co Ltd

Wall St
Price Targets

Price Targets Summary
Shenzhen Salubris Pharmaceuticals Co Ltd

Wall Street analysts forecast Shenzhen Salubris Pharmaceuticals Co Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shenzhen Salubris Pharmaceuticals Co Ltd is 47.2 CNY with a low forecast of 46.73 CNY and a high forecast of 48.58 CNY.

Lowest
Price Target
46.73 CNY
10% Downside
Average
Price Target
47.2 CNY
9% Downside
Highest
Price Target
48.58 CNY
7% Downside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Shenzhen Salubris Pharmaceuticals Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Shenzhen Salubris Pharmaceuticals Co Ltd stock?

The intrinsic value of one Shenzhen Salubris Pharmaceuticals Co Ltd stock under the Base Case scenario is 26.22 CNY.

Is Shenzhen Salubris Pharmaceuticals Co Ltd stock undervalued or overvalued?

Compared to the current market price of 52.02 CNY, Shenzhen Salubris Pharmaceuticals Co Ltd is Overvalued by 50%.

Back to Top